• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒患者凝血参数的变化趋势。

Trends of Coagulation Parameters in Human Immunodeficiency Virus Patients.

机构信息

Department of Hematology, Faculty of Medical Laboratory Sciences, Port Sudan Ahlia College, Port Sudan 33312, Sudan.

Department of Hematology, Faculty of Medical Laboratory Science, National University, Khartoum 11111, Sudan.

出版信息

Medicina (Kaunas). 2023 Oct 13;59(10):1826. doi: 10.3390/medicina59101826.

DOI:10.3390/medicina59101826
PMID:37893544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10608449/
Abstract

HIV disease is recognized to cause inconsistencies in coagulation via various pathways during infection. Some studies have indicated that HIV-infected patients are prone to developing thrombocytopenia, thrombosis, or autoantibodies that may cause difficulties in diagnosis. This study is intended to measure the trend of coagulation parameters in Sudanese patients with HIV. A cross-sectional study was carried out in patients with HIV admitted to the Sudan National AIDS Program (SNAP) from January 2018 to December 2019. Prothrombin time (PT), partial thromboplastin time (PTT), thrombin time (TT), D-dimer (DD), hemoglobin (HB), total lymphocyte count (TLC), platelet count (PLT), and a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13 (ADAMTS13), were evaluated among HIV Sudanese patients. Out of the 44 HIV patients included, 6 (13.6%) were found to have thrombotic thrombocytopenic purpura-like events and 12 (27.2%) had antiphospholipid antibodies, of whom 8 (66.6%) showed anticardiolipin antibody (1gG (75%) and IgM (25%)) and 4 showed lupus anticoagulants. The HB, TLC, and PLT values were found to be significantly lower in HIV patients than in control ( = 0.000, 0.000, and 0.050, respectively). The PT and ADAMTS13 values showed no significant difference between HIV patients and control ( = 0.613 and 0.266, respectively). The PTT, TT, and DD values were found to be augmented in HIV patients versus the control ( = 0.000). Thrombotic thrombocytopenic purpura-like events among HIV Sudanese patients were explored. In addition, antiphospholipid antibodies were strikingly seen in these patients. Additional research is anticipated to confirm these diagnoses.

摘要

艾滋病毒疾病被认为会通过感染过程中的各种途径导致凝血的不一致。一些研究表明,艾滋病毒感染患者容易发生血小板减少症、血栓形成或自身抗体,这可能导致诊断困难。本研究旨在测量苏丹艾滋病毒患者的凝血参数趋势。对 2018 年 1 月至 2019 年 12 月期间在苏丹国家艾滋病规划署(SNAP)就诊的艾滋病毒患者进行了横断面研究。评估了艾滋病毒苏丹患者的凝血酶原时间(PT)、部分凝血活酶时间(PTT)、凝血酶时间(TT)、D-二聚体(DD)、血红蛋白(HB)、总淋巴细胞计数(TLC)、血小板计数(PLT)和去整合素金属蛋白酶与血小板反应蛋白 1 型,成员 13(ADAMTS13)。在 44 名艾滋病毒患者中,有 6 名(13.6%)被发现患有血栓性血小板减少性紫癜样事件,12 名(27.2%)有抗磷脂抗体,其中 8 名(66.6%)显示抗心磷脂抗体(1gG(75%)和 IgM(25%)),4 名显示狼疮抗凝剂。与对照组相比,艾滋病毒患者的 HB、TLC 和 PLT 值明显较低(=0.000、0.000 和 0.050)。艾滋病毒患者和对照组之间的 PT 和 ADAMTS13 值无显著差异(=0.613 和 0.266)。与对照组相比,艾滋病毒患者的 PTT、TT 和 DD 值增加(=0.000)。探索了艾滋病毒苏丹患者的血栓性血小板减少性紫癜样事件。此外,这些患者明显出现抗磷脂抗体。预计将进行更多研究以确认这些诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb99/10608449/5a6402da950c/medicina-59-01826-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb99/10608449/945c98e80d05/medicina-59-01826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb99/10608449/ed33895ba63e/medicina-59-01826-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb99/10608449/5a6402da950c/medicina-59-01826-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb99/10608449/945c98e80d05/medicina-59-01826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb99/10608449/ed33895ba63e/medicina-59-01826-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb99/10608449/5a6402da950c/medicina-59-01826-g003.jpg

相似文献

1
Trends of Coagulation Parameters in Human Immunodeficiency Virus Patients.人类免疫缺陷病毒患者凝血参数的变化趋势。
Medicina (Kaunas). 2023 Oct 13;59(10):1826. doi: 10.3390/medicina59101826.
2
Absolute immature platelet count dynamics in diagnosing and monitoring the clinical course of thrombotic thrombocytopenic purpura.绝对未成熟血小板计数动态变化在血栓性血小板减少性紫癜临床诊断及病程监测中的应用
Transfusion. 2015 Apr;55(4):756-65. doi: 10.1111/trf.12912. Epub 2014 Nov 5.
3
Double positivity of anti-β-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies enhances both thrombosis and positivity of anti-ADAMTS13 antibody.抗β-糖蛋白I结构域I抗体和抗磷脂酰丝氨酸/凝血酶原抗体的双重阳性增强了血栓形成以及抗ADAMTS13抗体的阳性率。
J Thromb Thrombolysis. 2021 Nov;52(4):1133-1136. doi: 10.1007/s11239-021-02406-6. Epub 2021 Apr 29.
4
Serum concentrations of antiphospholipid and anticardiolipin antibodies are higher in HIV-infected women.血清中抗磷脂和抗心磷脂抗体的浓度在感染 HIV 的女性中更高。
Rheumatol Int. 2012 Jul;32(7):1927-32. doi: 10.1007/s00296-011-1859-1. Epub 2011 Mar 30.
5
ADAMTS13 activity levels in patients with human immunodeficiency virus-associated thrombotic microangiopathy and profound CD4 deficiency.人类免疫缺陷病毒相关血栓性微血管病及严重CD4缺乏患者的ADAMTS13活性水平
J Clin Apher. 2009;24(1):32-6. doi: 10.1002/jca.20189.
6
[Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].[血栓性血小板减少性紫癜——ADAMTS13活性的病理生理学及检测]
Rinsho Byori. 2015 Oct;63(10):1228-36.
7
ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases.血栓性微血管病及其他免疫介导疾病患者中的ADAMTS13自身抗体
Blood. 2005 Aug 15;106(4):1262-7. doi: 10.1182/blood-2004-11-4490. Epub 2005 May 12.
8
Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).ADAMTS13 在血栓性微血管病(包括血栓性血小板减少性紫癜[TTP])管理中的作用。
Br J Haematol. 2013 Nov;163(4):514-9. doi: 10.1111/bjh.12569. Epub 2013 Sep 20.
9
Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state.获得性血栓性血小板减少性紫癜(TTP)患者的自发性恢复:“亚临床”TTP 状态的观察。
Hematology. 2020 Dec;25(1):473-477. doi: 10.1080/16078454.2020.1848973.
10
Distinguishing and overlapping laboratory results of thrombotic microangiopathies in HIV infection: Can scoring systems assist?HIV 感染相关性血栓性微血管病的实验室检测结果鉴别与重叠:评分系统能否提供帮助?
J Clin Apher. 2022 Oct;37(5):460-467. doi: 10.1002/jca.22003. Epub 2022 Aug 20.

引用本文的文献

1
A Disintegrin and Metalloprotease with Thrombospondin Motif, Member 13, and Von Willebrand Factor in Relation to the Duality of Preeclampsia and HIV Infection.含血小板反应蛋白基序的解聚素和金属蛋白酶13与血管性血友病因子在子痫前期和HIV感染双重性中的关系
Int J Mol Sci. 2025 Apr 25;26(9):4103. doi: 10.3390/ijms26094103.
2
Outcomes of percutaneous endoscopic gastrostomy (PEG) in HIV patients.HIV患者经皮内镜下胃造口术(PEG)的治疗结果。
BMC Gastroenterol. 2024 Dec 31;24(1):482. doi: 10.1186/s12876-024-03574-4.

本文引用的文献

1
Coagulation Parameters in Human Immunodeficiency Virus Infected Patients: A Systematic Review and Meta-Analysis.人类免疫缺陷病毒感染患者的凝血参数:系统评价与荟萃分析
AIDS Res Treat. 2022 Apr 21;2022:6782595. doi: 10.1155/2022/6782595. eCollection 2022.
2
Renal Dysfunction among HIV-Infected Patients on Antiretroviral Therapy in Dar es Salaam, Tanzania: A Cross-Sectional Study.坦桑尼亚达累斯萨拉姆接受抗逆转录病毒治疗的艾滋病毒感染患者的肾功能障碍:一项横断面研究。
Int J Nephrol. 2020 Oct 8;2020:8378947. doi: 10.1155/2020/8378947. eCollection 2020.
3
Kidney Disease in HIV Infection.
HIV感染中的肾脏疾病
J Clin Med. 2019 Aug 19;8(8):1254. doi: 10.3390/jcm8081254.
4
Thrombotic thrombocytopenic purpura (TTP)-like syndrome in the HIV era.HIV时代的血栓性血小板减少性紫癜(TTP)样综合征。
Thromb J. 2018 Dec 13;16:35. doi: 10.1186/s12959-018-0189-x. eCollection 2018.
5
The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome.儿童期和成人期发病的抗磷脂综合征之间的差异
Front Pediatr. 2018 Nov 27;6:362. doi: 10.3389/fped.2018.00362. eCollection 2018.
6
Thrombotic Microangiopathies (TTP, HUS, HELLP).血栓性微血管病(血栓性血小板减少性紫癜、溶血尿毒综合征、伴有溶血、肝酶升高和血小板减少的子痫前期)
Hematol Oncol Clin North Am. 2017 Dec;31(6):1081-1103. doi: 10.1016/j.hoc.2017.08.010.
7
Thrombotic microangiopathy as an initial manifestation in HIV patients.血栓性微血管病作为HIV患者的初始表现
Indian J Crit Care Med. 2016 Jun;20(6):374-6. doi: 10.4103/0972-5229.183903.
8
Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.HIV-1感染过程中的免疫激活:病因、表型及治疗下的持续性
HIV Med. 2016 Feb;17(2):89-105. doi: 10.1111/hiv.12310. Epub 2015 Oct 10.
9
Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study.埃塞俄比亚西北部贡德尔市贡德尔大学医院抗逆转录病毒治疗门诊中接受高效抗逆转录病毒治疗的HIV阳性患者与未接受过治疗的患者的血液学和免疫学参数测定:一项比较性横断面研究
BMC Hematol. 2014 Mar 25;14(1):8. doi: 10.1186/2052-1839-14-8.
10
Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies.血栓性血小板减少性紫癜:基本病理生理学与治疗策略
Hematology Am Soc Hematol Educ Program. 2013;2013:292-9. doi: 10.1182/asheducation-2013.1.292.